手動復甦器市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球手動復甦器市場規模達5.324億美元，預計2034年將以6.5%的複合年成長率成長，達到9.899億美元。呼吸系統疾病的增加、手術量的增加以及產品的持續改進，都大大促進了該市場的擴張。這些復甦工具通常被稱為手動正壓通氣（PPV）設備，對於在關鍵時刻（無論是手術、急救還是重症監護）提供正壓通氣至關重要。隨著呼吸系統疾病和心臟驟停的負擔日益加重，醫院內外對攜帶式高效能手動復甦器的需求都在增加。

如今，先進的設計包括安全閥、抗菌材料以及方便用戶使用的功能，可為訓練有素的醫療專業人員和非專業急救人員提供支援。這種對易用性和可靠性的關注，正在推動其在高壓環境下的應用，因為在這些環境下，快速、精準的干涉至關重要。此外，支持可重複使用和耐滅菌的研發成果正在提升醫護人員的價值和長期實用性。隨著醫療保健系統持續為不可預測的緊急情況和公共衛生威脅做好準備，可靠的復甦解決方案的重要性仍然不容忽視。

2024年，自充氣式復甦器市場規模達2.465億美元。這類復甦器因其操作簡便、無需外部氧源即可工作而備受青睞，從而提升了其在快速緊急情況下的機動性和有效性。在缺乏穩定醫療基礎設施的環境中，自充氣式復甦器的應用顯著提升了其市場佔有率。由於其可靠性，自充氣式復甦器在創傷、心肺復甦術和重大醫療事件中仍然是首選。它們在不可預測的條件下一致的表現增強了市場需求，尤其是在急診、救護車和救災行動中，這些場合需要立即且大量地提供可靠的呼吸支援。

一次性復甦器市場在2024年達到3.004億美元，預計到2034年將以6.8%的複合年成長率成長。隨著醫療系統加強感染控制規程，一次性復甦器因其一次性使用的特性，降低了交叉污染的風險，其受歡迎程度急劇上升。這些復甦器無需消毒，重量輕，操作簡便，非常適合救護車、野戰醫院和疫情應變小組等時間緊迫的場合。在公共衛生緊急事件、大規模傷亡事件和軍事行動中，它們的作用尤其重要，因為在這些情況下，衛生、準備就緒和快速部署至關重要。這些特性使其成為大規模緊急準備策略中值得信賴的資產。

美國手動復甦器市場在2024年創收1.876億美元，預計2025年至2034年間的複合年成長率將達到5.9%。該地區的成長主要源於呼吸系統疾病和心臟病急症病例的增加。美國擁有世界上最先進的醫療保健體系之一，並廣泛應用高階復甦器技術。公共和私營機構對急救護理和新生兒設施的大量投資持續刺激了需求。美國致力於最大限度地減少醫院內感染，這進一步推動了一次性產品的日益普及。包括限壓閥和先進的生物相容性材料等技術進步，持續提升了產品的安全性和功能性。

全球手動復甦器市場的知名企業包括 Teleflex、AirLife、ROMSONS、Besmed、Laerdal、GALEMED、Fisher & Paykel Healthcare、FLEXICARE、MercuryMedical、HSINER、ASIA CONNECTION、Angiplast、Medline、BOENMED、Neokraft 和 Classic Plastics。為鞏固市場地位，手動復甦器產業的企業正專注於創新、產品多功能性和法規遵循。許多公司正在透過壓力控制系統、抗菌組件和人體工學設計來增強其產品線，以支援在關鍵環境中的快速部署和易用性。全球企業正增加一次性產品的投資，以符合感染控制重點。與緊急醫療服務和醫院建立策略夥伴關係有助於提高市場滲透率，而向新興市場的地理擴張則增強了分銷能力。企業也正在利用先進的製造技術來降低成本並提高產品品質。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 供應商格局
  • 每個階段的增值
  • 影響價值鏈的因素
• 產業衝擊力
  • 成長動力
    • 呼吸系統疾病發生率不斷上升
    • 復甦設備的技術進步
    • 外科手術增多
  • 產業陷阱與挑戰
    • 使用不當或過度換氣的風險
  • 市場機會
• 成長潛力分析
• 監管格局
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 報銷場景
  • 報銷政策對市場成長的影響
• 波特的分析
• PESTEL分析
• 差距分析
• 未來市場趨勢
• 價值鏈分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

• 主要趨勢
• 自充氣復甦器
• 流量充氣復甦器
• T 型件

第6章：市場估計與預測：按方式，2021 - 2034 年

• 主要趨勢
• 一次性的
• 可重複使用的

第7章：市場估計與預測：按材料，2021 - 2034 年

• 主要趨勢
• 矽酮
• PVC
• 橡皮

第8章：市場估計與預測：依病患類型，2021 - 2034 年

• 主要趨勢
• 成人
• 兒科
• 新生兒

第9章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 慢性阻塞性肺臟疾病
• 心肺驟停
• 其他應用

第 10 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第 11 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第12章：公司簡介

• ANGIPLAST
• AirLife
• ASIA CONNECTION
• Besmed
• BOENMED
• Fisher & Paykel HEALTHCARE
• Flexicare
• GaleMed
• HSINER
• Laerdal
• MEDLINE
• MercuryMedical
• NEOKRAFT
• Romsons
• Teleflex

The Global Manual Resuscitators Market was valued at USD 532.4 million in 2024 and is estimated to grow at a CAGR of 6.5% to reach USD 989.9 million by 2034. A rising number of respiratory ailments, increasing surgical volumes, and continuous product enhancements are contributing significantly to this market's expansion. These resuscitation tools, often referred to as hand-operated PPV devices, are essential for delivering positive pressure ventilation in critical moments-whether during surgery, emergencies, or intensive care. With the rising burden of respiratory conditions and cardiac arrests, the demand for portable, effective manual resuscitators is growing both inside and outside hospital environments.

Advanced designs now include safety valves, antimicrobial materials, and user-friendly features that support both trained medical professionals and non-specialist responders. This focus on ease of use and reliability is boosting adoption in high-pressure settings where quick, precise intervention is essential. Additionally, developments that support reusability and withstand sterilization are increasing value and long-term utility for care providers. As healthcare systems continue to prepare for unpredictable emergencies and public health threats, the importance of dependable resuscitation solutions remains robust.

In 2024, the self-inflating resuscitators segment generated USD 246.5 million. These resuscitators are favored for their ease of operation and the ability to function independently of external oxygen sources, which enhances mobility and effectiveness in fast-paced emergency scenarios. Their utility in environments without stable medical infrastructure has significantly strengthened their market share. These devices continue to be the top choice during trauma, CPR, and critical medical events due to their reliability. Their consistent performance in unpredictable conditions reinforces demand, particularly in emergency departments, ambulances, and disaster relief operations where dependable respiratory support is required immediately and in large volumes.

The disposable resuscitator segment recorded USD 300.4 million in 2024 and is forecasted to grow at a CAGR of 6.8% through 2034. As healthcare systems tighten infection control protocols, disposable options are seeing a sharp rise in preference due to their single-use nature, which reduces cross-contamination risks. These resuscitators eliminate the need for sterilization, are lightweight, easy to operate, and perfectly suited for time-critical settings like ambulances, field hospitals, and pandemic response teams. Their role becomes even more vital during public health emergencies, mass casualty events, and military operations, where hygiene, readiness, and rapid deployment are crucial. These characteristics make them a dependable asset in large-scale emergency preparedness strategies.

U.S. Manual Resuscitators Market generated USD 187.6 million in 2024 and is expected to grow at a CAGR of 5.9% between 2025 and 2034. Growth in this region is driven by rising cases of respiratory conditions and cardiac emergencies. The U.S. benefits from having one of the world's most advanced healthcare systems, with widespread use of premium resuscitator technologies. Substantial investments in emergency care and neonatal facilities by both public and private entities continue to boost demand. An increasing shift toward disposable products is further supported by the country's focus on minimizing hospital-acquired infections. Technological progress, including features like pressure-limiting valves and advanced, biocompatible materials, continues to elevate product safety and functionality.

Notable players in the Global Manual Resuscitators Market include Teleflex, AirLife, ROMSONS, Besmed, Laerdal, GALEMED, Fisher & Paykel Healthcare, FLEXICARE, MercuryMedical, HSINER, ASIA CONNECTION, Angiplast, Medline, BOENMED, Neokraft, and Classic Plastics. To reinforce their market position, companies in the manual resuscitators industry are focusing on innovation, product versatility, and regulatory compliance. Many firms are enhancing their product lines with pressure-control systems, antimicrobial components, and ergonomic designs to support rapid deployment and ease of use in critical settings. Global players are increasingly investing in disposable variants to align with infection control priorities. Strategic partnerships with emergency medical services and hospitals help improve market penetration, while geographic expansion into emerging markets boosts distribution capabilities. Companies are also leveraging advanced manufacturing technologies to reduce costs and enhance product quality.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Modality
  • 2.2.4 Material
  • 2.2.5 Patient type
  • 2.2.6 Application
  • 2.2.7 End use
• 2.3 CXO perspectives: strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of respiratory disorders
    • 3.2.1.2 Technological advancements in resuscitation devices
    • 3.2.1.3 Rising surgical procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Risk of improper use or hyperventilation
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
  • 3.6.1 Impact of reimbursement policies on market growth
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Gap analysis
• 3.10 Future market trends
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 By region
    • 4.3.1.1 North America
    • 4.3.1.2 Europe
    • 4.3.1.3 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Self-inflating resuscitators
• 5.3 Flow-inflating resuscitators
• 5.4 T-piece

Chapter 6 Market Estimates and Forecast, By Modality, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Disposable
• 6.3 Reusable

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Silicone
• 7.3 PVC
• 7.4 Rubber

Chapter 8 Market Estimates and Forecast, By Patient type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Adult
• 8.3 Pediatric
• 8.4 Neonatal

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Chronic obstructive pulmonary disease
• 9.3 Cardiopulmonary arrest
• 9.4 Other applications

Chapter 10 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 Hospitals
• 10.3 Ambulatory surgical centers
• 10.4 Other end use

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Netherlands
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 Japan
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
• 11.6 Middle East and Africa
  • 11.6.1 South Africa
  • 11.6.2 Saudi Arabia
  • 11.6.3 UAE

Chapter 12 Company Profiles

• 12.1 ANGIPLAST
• 12.2 AirLife
• 12.3 ASIA CONNECTION
• 12.4 Besmed
• 12.5 BOENMED
• 12.6 Fisher & Paykel HEALTHCARE
• 12.7 Flexicare
• 12.8 GaleMed
• 12.9 HSINER
• 12.10 Laerdal
• 12.11 MEDLINE
• 12.12 MercuryMedical
• 12.13 NEOKRAFT
• 12.14 Romsons
• 12.15 Teleflex